world-immunology-cancer-summit-2019-keynote

5 / 6

Page 12
December 09-10, 2019 | Barcelona, Spain
Volume 02
Journal of Immune Disorders & Therapy
J Immune Disord Ther, Volume 02
World Immunology 2019 & Cancer Summit 2019
December 09-10, 2019
9th WORLD CONGRESS ON
IMMUNOLOGY AND CANCER
Human CD8+ CD25+ CD127low regulatory T cells: MicroRNA signature and impact on
TGF-β and IL-10 expression
Regulatory T cells (Tregs) are central for maintaining immune balance and their dysfunction drives the expansion of critical
immunologic disorders. During the past decade, microRNAs (miRNAs) have emerged as potent regulators of gene
expression among which immune related genes and their immunomodulatory properties have been associated with different
immune-based diseases. The miRNA signature of human peripheral blood (PB) CD8+ CD25 + CD127low Tregs has not been
described yet. We thus identified, using TaqMan Low-DensityArray (TLDA) technique followed by individual quantitative real-
time PCR (qRT-PCR) confirmation, fourteen miRNAs, among which twelve were downregulated whilst two were upregulated
in CD8+ CD25+ CD127low Tregs in comparison to CD8+CD25- T cells. In a next step, microRNAData Integration Portal (mirDIP)
was used to identify potential miRNA target sites in the 3’UTR of key Treg cell-immunomodulatory genes with special focus
on IL-10 and TGF-β. Having identified potential miR target sites in the 3’UTR of IL-10 (miR-27b-3p, miR-340-5p) and TGF-β
(miR-330-3p), we showed following transfection, and transduction assays that overexpression of two under-expressed miRNAs,
miR-27b-3p and miR-340-5p, downregulates IL-10 expression upon targeting its 3’UTR. Similarly, overexpression of miR-
330-3p negatively regulates TGF-β expression. These results highlight an important impact of the CD8+ Treg mirnome on the
expression of genes with significant implication in immunosuppression. These observations could help in better understanding
the mechanism orchestrating Treg immunosuppressive function towards unravelling new targets for treating auto- immune
pathologies and cancer.
Biography
Hussein Fayyad-Kazan is a full time professor at the Lebanese University-Faculty of Science. He got his Bachelor degree in Biochemistry in
2005 from the Lebanese University-Faculty of Science. Later on, he continued his studies in the Free University of Brussels (ULB) where got
his Master’s Degree in Molecular Biology and Biotechnology in 2007 and then a PhD in December 2010. Thereafter, He did a postdoc in the
Laboratory of Experimental Hematology-Jules Bordet Institute-ULB till September 2018 where he worked on several Molecular Immunology
topics. He have about sixty scientific papers being published in high impact factor journals. His research work is focused on Cancer Biology
and Molecular Immunology.
Hussein Fayyad-Kazan
Lebanese University, Lebanon